Lv21
180 积分 2024-08-20 加入
In vivo nano-engineering T cells for CAR-T therapy
2小时前
待确认
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
11个月前
已完结
Intrinsic targeting of host RNA by Cas13 constrains its utility
1年前
已完结
Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
1年前
已完结
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
1年前
已完结
Screening circular RNAs with functional potential using the RfxCas13d/BSJ-gRNA system
1年前
已完结
Laboratory Testing for Non-criteria Antiphospholipid Antibodies: Anti-phosphatidylserine/Prothrombin Antibodies (aPS/PT)
1年前
已完结
Laboratory Testing for Non-criteria Antiphospholipid Antibodies: Anti-phosphatidylserine/Prothrombin Antibodies (aPS/PT)
1年前
已关闭
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
1年前
已完结
Prediction of efficiencies for diverse prime editing systems in multiple cell types
1年前
已完结
皖公网安备34019202002308
